• EnglishEnglish
  • EspañolEspañol
    • Home
    • About Us
      • Research Team
      • Self-sustainability Principle
      • Effective Collaboration
    • Research
      • Screening of Microbiota Composition in MS
      • Bacterial Transfer into Gnotobiotic Mice
      • Immunological and Molecular Studies of the Gut-immune System/Brain Axis
      • Clinical Trials
      • Publications
      • SOPs and Supplies
    • Study Participants
      • Online Food Questionnaire Instructions
      • Study Progress
      • Instructions for Stool Sample Acquisition
    • Links
    • Contact Us
      • Donate

    the_title();

    Study Videos

    Kit Contents

    Sample Collection

    Packing

    Contact Us

    Boston: (415) 514-2132
    Boston@imsms.org
    Buenos Aires: +54 (11) 5777-3200 int.2704/2708
    BuenosAires@imsms.org
    Edinburgh: +44 0131-465-9517
    Edinburgh@imsms.org
    New York: (212) 241-6854
    NewYork@imsms.org
    Philadelphia: (215) 220-9384
    Philadelphia@imsms.org
    Pittsburgh: (412) 254-4883
    Pittsburgh@imsms.org
    San Diego: (858) 246-2905
    SanDiego@imsms.org
    San Francisco: (415) 502-7197
    SanFrancisco@imsms.org
    San Sebastian: +34 943-007-246
    SanSebastian@imsms.org

    FAQs

    • Do I qualify for the International MS Microbiome Study (iMSMS)?
    • What is this study?
    • What causes multiple sclerosis?
    • How will we do it?
    • Why study bacteria?
    • What can be done with this information?

    Our Mission

    We will investigate the role of gut bacteria (microbiota) and their genes (microbiome) in multiple sclerosis (MS) and use that understanding to design a clinical trial that will represent an entirely new approach to the treatment of multiple sclerosis.

    Copyright © 2020. All Rights reserved.

    Website design courtesy of Temperies